Foresight News 消息,临床阶段制药公司 Artelo Biosciences(纳斯达克代码:ARTL)宣布完成 947.5 万美元场外私募融资,将用于启动以 Solana(SOL)为核心的数字资产储备战略。该公司成为首家将 SOL 纳入储备资产的上市制药企业。 [查看更多]
Foresight News 消息,临床阶段制药公司 Artelo Biosciences(纳斯达克代码:ARTL)宣布完成 947.5 万美元场外私募融资,将用于启动以 Solana(SOL)为核心的数字资产储备战略。该公司成为首家将 SOL 纳入储备资产的上市制药企业。 [查看更多]
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.